IMPAX To Present At Wachovia Securities 2002 Nantucket Equity Conference

June 19, 2002
Company Presentation Wednesday, June 26, 2002, at 9:00 a.m. ET

June 19, 2002 -- IMPAX Laboratories, Inc. (Nasdaq NM: IPXL) today announced that management will present at the Wachovia Securities 2002 Nantucket Equities Conference on Wednesday, June 26, 2002 at 9:00 a.m. Eastern Time.

The conference, which includes more than 150 companies covering a range of industries and market capitalizations, will be held at the Harbor House in Nantucket, Mass., and attendees will include invited institutional money managers.

IMPAX's presentation can be heard live on the Internet. In addition, an audio replay will be available the following business day for a period of 30 days. Please visit the investor relations section of IMPAX's Website at http://www.impaxlabs.com/invest for a link to the Company's presentation.

IMPAX currently has 15 ANDA filings pending at the FDA that address more than $8 billion in U.S. branded product sales. Nine of these filings were made under Paragraph IV of the Hatch-Waxman Amendments.

IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and niche generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and intends to market its branded products through the IMPAX Pharmaceuticals division. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at: www.impaxlabs.com.